JANE STREET GROUP, LLC - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$30,880
-95.7%
60,667
+41.2%
0.00%
-100.0%
Q2 2020$714,000
+55.6%
42,979
+6.6%
0.00%
Q1 2020$459,00040,3170.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 810,073$9,980,0006.05%
EcoR1 Capital, LLC 3,915,880$48,244,0004.35%
Opaleye Management Inc. 1,381,300$17,018,0003.34%
Avidity Partners Management LP 210,000$2,587,0001.63%
ACUTA CAPITAL PARTNERS, LLC 372,500$4,589,0001.14%
Boxer Capital, LLC 1,009,255$12,434,0000.70%
Redmile Group, LLC 1,920,831$23,665,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 379,998$4,682,0000.39%
Sio Capital Management, LLC 88,185$1,086,0000.26%
Baker Brothers Advisors 3,397,740$41,860,0000.22%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders